Failure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naïve individuals is related to differences in antibody profiles before vaccination, not after

Clinical and Vaccine Immunology

Volumn 19, Issue 3, 2012, Pages 418-428

  Tan, Xiaolin ^a,c   Chun, Sookhee ^a   Pablo, Jozelyn ^a   Felgner, Philip ^a   Liang, Xiaowu ^b   Davies, D Huw ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Antigen Discovery Inc   (United States)

^c CoreLogic ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEOME; SMALLPOX VACCINE;

AMINO ACID SEQUENCE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; CLINICAL SKIN REACTION; CONTROLLED STUDY; CROSS REACTION; DRUG EFFICACY; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PRIORITY JOURNAL; PROTEIN MICROARRAY; SEQUENCE HOMOLOGY; SMALLPOX; VACCINE FAILURE; VACCINIA VIRUS; VIRUS NEUTRALIZATION;

ANTIBODIES, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PROTEIN ARRAY ANALYSIS; SKIN; SMALLPOX VACCINE; VACCINIA VIRUS; VIRAL PROTEINS;

EID: 84857991164     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05521-11     Document Type: Article

References (39)

1. Amanna IJ, Slifka MK, Crotty S. 2006. Immunity and immunological memory following smallpox vaccination. Immunol. Rev. 211:320-337. (Pubitemid 43882983)
2. Baldi P, Hatfield GW. 2002. DNA microarrays and gene expression: from experiments to data analysis and modeling. Cambridge University Press, Cambridge, United Kingdom.
3. Baldi P, Long AD. 2001. A Bayesian framework for the analysis of microarray expression data: regularized t-test and statistical inferences of gene changes. Bioinformatics 17:509-519. (Pubitemid 32600497)
4. Belshe RB, et al. 2004. Dose-dependent neutralizing-antibody responses to vaccinia. J. Infect. Dis. 189:493-497. (Pubitemid 38210586)
5. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57:289-300.
6. Davies DH, et al. 2005. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl. Acad. Sci. U. S. A. 102:547-552. (Pubitemid 40282702)
7. Davies DH, et al. 2005. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J. Virol. 79:11724-11733. (Pubitemid 41279291)
8. Davies DH, et al. 2007. Proteome-wide analysis of the serological response to vaccinia and smallpox. Proteomics 7:1678-1686. (Pubitemid 46841828)
9. Davies DH, et al. 2008. Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus Ankara is comparable to that of Dryvax. J. Virol. 82:652-663.
10. Durbin BP, Hardin JS, Hawkins DM, Rocke DM. 2002. A variance-stabilizing transformation for gene-expression microarray data. Bioinformatics 18(Suppl 1):S105-S110. (Pubitemid 41185643)
11. Frey SE, et al. 2002. Clinical responses to undiluted and diluted smallpox vaccine. N. Engl. J. Med. 346:1265-1274. (Pubitemid 34429457)
12. Frey SE, et al. 2002. Dose-related effects of smallpox vaccine. N. Engl. J. Med. 346:1275-1280. (Pubitemid 34429458)
13. Frey SE, Newman FK, Yan L, Lottenbach KR, Belshe RB. 2003. Response to smallpox vaccine in persons immunized in the distant past. JAMA 289:3295-3299. (Pubitemid 37430084)
14. Gassmann R, et al. 2008. Clinical and immune response to undiluted and diluted smallpox vaccine. Swiss Med. Wkly. 138:392-397.
15. Hermanson G, et al. 2012. Measurement of antibody responses to modified vaccinia virus Ankara (MVA) and Dryvax® using proteome microarrays and development of recombinant protein ELISAs. Vaccine 30:614-625.
16. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M. 2002. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18(Suppl 1):S96-S104. (Pubitemid 41185642)
17. Jing L, et al. 2008. An extremely diverse CD4 response to vaccinia virus in humans is revealed by proteome-wide T-cell profiling. J. Virol. 82:7120-7134. (Pubitemid 351977730)
18. Jing L, et al. 2009. ORFeome approach to the clonal, HLA allele-specific CD4 T-cell response to a complex pathogen in humans. J. Immunol. Methods 347:36-45.
19. Jones-Trower A, et al. 2005. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin. Virology 343:128-140. (Pubitemid 41572239)
20. Klemperer N, Ward J, Evans E, Traktman P. 1997. The vaccinia virus I1 protein is essential for the assembly of mature virions. J. Virol. 71:9285-9294. (Pubitemid 27492370)
21. Kreil DP, Karp NA, Lilley KS. 2004. DNA microarray normalization methods can remove bias from differential protein expression analysis of 2D difference gel electrophoresis results. Bioinformatics 20:2026-2034. (Pubitemid 39236554)
22. Lai CF, Gong SC, Esteban M. 1991. The purified 14-kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals. J. Virol. 65:5631-5635.
23. Lane JM, Goldstein J. 2003. Evaluation of 21st-century risks of smallpox vaccination and policy options. Ann. Intern. Med. 138:488-493. (Pubitemid 38129027)
24. Liu X, Kremer M, Broyles SS. 2004. A natural vaccinia virus promoter with exceptional capacity to direct protein synthesis. J. Virol. Methods 122:141-145. (Pubitemid 39470184)
25. Long AD, et al. 2001. Improved statistical inference from DNA microarray data using analysis of variance and a Bayesian statistical framework. Analysis of global gene expression in Escherichia coli K-12. J. Biol. Chem. 276:19937-19944.
26. Martin DB. 2002. The cause of death in smallpox: an examination of the pathology record. Mil. Med. 167:546-551. (Pubitemid 34779083)
27. Maurer DM, Harrington B, Lane JM. 2003. Smallpox vaccine: contraindications, administration, and adverse reactions. Am. Fam. Physician 68:889-896.
28. Moss B. 2011. Smallpox vaccines: targets of protective immunity. Immunol. Rev. 239:8-26.
29. Patel DD, Pickup DJ, Joklik WK. 1986. Isolation of cowpox virus A-type inclusions and characterization of their major protein component. Virology 149:174-189. (Pubitemid 16127815)
30. Puissant-Lubrano B, et al. 2010. Control of vaccinia virus skin lesions by long-term-maintained IFN-gamma+TNF-alpha+ effector/memory CD4+ lymphocytes in humans. J. Clin. Invest. 120:1636-1644.
31. Putz MM, Midgley CM, Law M, Smith GL. 2006. Quantification of antibody responses against multiple antigens of the two infectious forms of vaccinia virus provides a benchmark for smallpox vaccination. Nat. Med. 12:1310-1315. (Pubitemid 44706934)
32. Rock MT, Yoder SM, Talbot TR, Edwards KM, Crowe JE, Jr. 2006. Cellular immune responses to diluted and undiluted Aventis Pasteur smallpox vaccine. J. Infect. Dis. 194:435-443. (Pubitemid 44162654)
33. Sakhatskyy P, Wang S, Chou TH, Lu S. 2006. Immunogenicity and protection efficacy of monovalent and polyvalent poxvirus vaccines that include the D8 antigen. Virology 355:164-174. (Pubitemid 44692776)
34. Seaman MS, et al. 2010. Effect of vaccination with modified vaccinia Ankara (ACAM3000) on subsequent challenge with Dryvax. J. Infect. Dis. 201:1353-1360.
35. Sundaresh S, et al. 2006. Identification of humoral immune responses in protein microarrays using DNA microarray data analysis techniques. Bioinformatics 22:1760-1766. (Pubitemid 44288339)
36. Sundaresh S, et al. 2007. From protein microarrays to diagnostic antigen discovery: a study of the pathogen Francisella tularensis. Bioinformatics 23:i508-i518. (Pubitemid 47244438)
37. Szajner P, Weisberg AS, Lebowitz J, Heuser J, Moss B. 2005. External scaffold of spherical immature poxvirus particles is made of protein trimers, forming a honeycomb lattice. J. Cell Biol. 170:971-981. (Pubitemid 41306296)
38. Talbot TR, et al. 2004. Vaccination success rate and reaction profile with diluted and undiluted smallpox vaccine: a randomized controlled trial. JAMA 292:1205-1212. (Pubitemid 39167411)
39. Thomas G, Frenzel E, Hanna H. 2004. Smallpox vaccine: "nontake"responses in previously vaccinated adults. Infect. Control Hosp. Epidemiol. 25:613-615. (Pubitemid 38954496)